pISSN 1226-6051
eISSN 2508-786X

Table. 4.

Table. 4.

Adverse event after administration of methotrexate

Normal (N=62)Delayed (N=23)

TotalGrades 3-4TotalGrades 3-4
Renal and hepatic toxicities
 Creatinine increased7 (11.3)0 (0.0)5 (21.7)0 (0.0)
 ASTa increased52 (83.9)10 (16.1)16 (69.6)7 (30.4)
 ALTb increased48 (77.4)7 (11.3)19 (82.6)3 (13.0)

Hematological toxicities
 WBC decreased61 (98.4)39 (62.9)23 (100.0)18 (78.3)
 Neutrophil count decreased52 (83.9)35 (56.5)21 (91.3)14 (60.9)
 Platelet decreased43 (69.4)11 (17.7)18 (78.3)5 (21.7)
 Anemia62 (100.0)34 (54.8)23 (100.0)16 (69.6)

*Number (%)

Aspartate aminotransferase

Alanine aminotransferase

Korean J Clin Pharm 2019;29:101-8 https://doi.org/10.24304/kjcp.2019.29.2.101
© 2019 Korean J Clin Pharm